Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2025 13:05 ET | Source: ProText Mobility, Inc.

Protext Mobility, Inc. (OTC: TXTM) Provides Shareholder Update

Protext Mobility, Inc. (OTC: TXTM) Provides Shareholder Update
November 18, 2025 08:45 ET | Source: MarketNewsUpdates.com

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

MarketNewsUpdates News Commentary NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The advance anti-aging therapies market is expanding quickly fueled by a larger senior population and increased...
November 17, 2025 08:10 ET | Source: Cytokinetics, Incorporated

Cytokinetics Supports American Heart Association Initiative to Improve Care for People Living With Hypertrophic Cardiomyopathy

System of Care to Advance Care for the Most Commonly Inherited Heart Disease SOUTH SAN FRANCISCO, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced its...
November 13, 2025 09:00 ET | Source: EuroDry Ltd.

EuroDry Ltd. Reports Results for the Quarter and Nine-Month Period Ended September 30, 2025 and Announces Debt Financing Arrangements for its Two Ultramax Newbuildings

ATHENS, Greece, Nov. 13, 2025 (GLOBE NEWSWIRE) -- EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for...
November 12, 2025 16:05 ET | Source: Echo IQ

Echo IQ Highlights Market Potential for EchoSolv AS Following Presentation of New Data for Severe Aortic Stenosis (AS) Presented at AHA Scientific Sessions 2025

Investigator-initiated study shows potential for EchoSolv AS to drive improved patient outcomes when used to support cardiologist in identifying severe AS particularly in womenNEDA study of 1.2M...
November 12, 2025 16:01 ET | Source: Heartflow, Inc.

Heartflow Reports Third Quarter 2025 Financial Results

MOUNTAIN VIEW, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today...
November 12, 2025 07:01 ET | Source: Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

PDUFA Target Date of December 13, 2025 for CARDAMYST™ (etripamil) Nasal Spray in Paroxysmal Supraventricular Tachycardia (PSVT) Promotional Launch Plans Set with Quick-Start Capability Upon...
November 11, 2025 08:05 ET | Source: iRhythm

iRhythm Technologies Announces Publication of Large-Scale Study in Heart Rhythm and New Data Presented at AHA Scientific Sessions 2025

New Heart Rhythm Journal publication and AHA 2025 data reinforce Zio LTCM clinical value and real-world evidence supporting proactive cardiac monitoring.
November 10, 2025 15:17 ET | Source: Intellia Therapeutics, Inc.

Intellia Therapeutics Presents Positive Longer-Term Phase 1 Data of Nexiguran Ziclumeran (nex-z) in Patients with Transthyretin (ATTR) Amyloidosis with Cardiomyopathy

One-time treatment of nex-z led to consistently rapid, deep and durable reduction in serum TTR through three years of follow-upConsistent trend in disease stability or improvement in multiple measures...
November 10, 2025 13:30 ET | Source: EuroDry Ltd.

EuroDry Ltd. Sets Date for the Release of Third Quarter 2025 Results, Conference Call and Webcast

ATHENS, Greece, Nov. 10, 2025 (GLOBE NEWSWIRE) -- EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for...